Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Thembi Mdluli"'
Autor:
Thembi Mdluli, Bonnie M. Slike, Daniel J. Curtis, Zhanna Shubin, Ursula Tran, Yifan Li, Vincent Dussupt, Letzibeth Mendez-Rivera, Suteeraporn Pinyakorn, Daniel J. Stieh, Frank L. Tomaka, Hanneke Schuitemaker, Maria G. Pau, Donn J. Colby, Eugène Kroon, Carlo Sacdalan, Mark de Souza, Nittaya Phanupak, Denise C. Hsu, Jintanat Ananworanich, Julie A. Ake, Lydie Trautmann, Sandhya Vasan, Merlin L. Robb, Shelly J. Krebs, Dominic Paquin-Proulx, Morgane Rolland
Publikováno v:
Cell Reports, Vol 43, Iss 6, Pp 114344- (2024)
Summary: A heterologous Ad26/MVA vaccine was given prior to an analytic treatment interruption (ATI) in people living with HIV-1 (mainly CRF01_AE) who initiated antiretroviral treatment (ART) during acute HIV-1. We investigate the impact of Ad26/MVA
Externí odkaz:
https://doaj.org/article/2a53194be3584d4cb1d89d2981acfbb5
Autor:
Yifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, Bradley Beckman, Thembi Mdluli, Isabella Swafford, Sandra V. Mayer, Jocelyn King, Courtney Corbitt, Jeffrey R. Currier, Heather Liu, Allahna Esber, Suteeraporn Pinyakorn, Ajay Parikh, Leilani V. Francisco, Nittaya Phanuphak, Jonah Maswai, John Owuoth, Hannah Kibuuka, Michael Iroezindu, Emmanuel Bahemana, Sandhya Vasan, Julie A. Ake, Kayvon Modjarrad, Gregory Gromowski, Dominic Paquin-Proulx, Morgane Rolland
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 11, Pp 2214-2225 (2022)
Prior immune responses to coronaviruses might affect human SARS-CoV-2 response. We screened 2,565 serum and plasma samples collected from 2013 through early 2020, before the COVID-19 pandemic began, from 2,250 persons in 4 countries in Africa (Kenya,
Externí odkaz:
https://doaj.org/article/aefcd1a5a71b4b3f8a8cbb0b90b6bda0
Autor:
Thembi Mdluli, Ningbo Jian, Bonnie Slike, Dominic Paquin-Proulx, Gina Donofrio, Aljawharah Alrubayyi, Syna Gift, Rebecca Grande, Mary Bryson, Anna Lee, Vincent Dussupt, Letzibeth Mendez-Rivera, Eric Sanders-Buell, Agnès-Laurence Chenine, Ursula Tran, Yifan Li, Eric Brown, Paul T Edlefsen, Robert O'Connell, Peter Gilbert, Sorachai Nitayaphan, Punnee Pitisuttihum, Supachai Rerks-Ngarm, Merlin L Robb, Robert Gramzinski, Galit Alter, Sodsai Tovanabutra, Ivelin S Georgiev, Margaret E Ackerman, Victoria R Polonis, Sandhya Vasan, Nelson L Michael, Jerome H Kim, Michael A Eller, Shelly J Krebs, Morgane Rolland
Publikováno v:
PLoS Pathogens, Vol 17, Iss 3, p e1009386 (2021)
[This corrects the article DOI: 10.1371/journal.ppat.1009101.].
Externí odkaz:
https://doaj.org/article/ea4fb3ac1eac43f48970836217c74d35
Autor:
Thembi Mdluli, Ningbo Jian, Bonnie Slike, Dominic Paquin-Proulx, Gina Donofrio, Aljawharah Alrubayyi, Syna Gift, Rebecca Grande, Mary Bryson, Anna Lee, Vincent Dussupt, Letzibeth Mendez-Riveria, Eric Sanders-Buell, Agnès-Laurence Chenine, Ursula Tran, Yifan Li, Eric Brown, Paul T Edlefsen, Robert O'Connell, Peter Gilbert, Sorachai Nitayaphan, Punnee Pitisuttihum, Supachai Rerks-Ngarm, Merlin L Robb, Robert Gramzinski, Galit Alter, Sodsai Tovanabutra, Ivelin S Georgiev, Margaret E Ackerman, Victoria R Polonis, Sandhya Vasan, Nelson L Michael, Jerome H Kim, Michael A Eller, Shelly J Krebs, Morgane Rolland
Publikováno v:
PLoS Pathogens, Vol 16, Iss 12, p e1009101 (2020)
The RV144 vaccine efficacy clinical trial showed a reduction in HIV-1 infections by 31%. Vaccine efficacy was associated with stronger binding antibody responses to the HIV Envelope (Env) V1V2 region, with decreased efficacy as responses wane. High l
Externí odkaz:
https://doaj.org/article/12e377eb6a71441cbca66bb27d1e7ec0
Autor:
Kier Om, Dominic Paquin-Proulx, Maria Montero, Kristina Peachman, Xiaoying Shen, Lindsay Wieczorek, Zoltan Beck, Joshua A Weiner, Dohoon Kim, Yifan Li, Thembi Mdluli, Zhanna Shubin, Christopher Bryant, Vishakha Sharma, Andrey Tokarev, Peter Dawson, Yohann White, Oliver Appelbe, Nichole R Klatt, Sodsai Tovanabutra, Jacob D Estes, Gary R Matyas, Guido Ferrari, Carl R Alving, Georgia D Tomaras, Margaret E Ackerman, Nelson L Michael, Merlin L Robb, Victoria Polonis, Morgane Rolland, Michael A Eller, Mangala Rao, Diane L Bolton
Publikováno v:
PLoS Pathogens, Vol 16, Iss 9, p e1008764 (2020)
To augment HIV-1 pox-protein vaccine immunogenicity using a next generation adjuvant, a prime-boost strategy of recombinant modified vaccinia virus Ankara and multimeric Env gp145 was evaluated in macaques with either aluminum (alum) or a novel lipos
Externí odkaz:
https://doaj.org/article/7a6c977bbc934d51bd9ae6ad3d6245bd
Publikováno v:
PLoS Computational Biology, Vol 11, Iss 9, p e1004488 (2015)
This model-based design of experiments (MBDOE) method determines the input magnitudes of an experimental stimuli to apply and the associated measurements that should be taken to optimally constrain the uncertain dynamics of a biological system under
Externí odkaz:
https://doaj.org/article/f37c2bd883b74af092130b3677abaacc
Autor:
Thembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, Daniel B. Reeves, E. Fabian Cardozo-Ojeda, Adam Yates, Jintana Intasan, Somporn Tipsuk, Nittaya Phanuphak, Carlo Sacdalan, Donn J. Colby, Eugène Kroon, Trevor A. Crowell, Rasmi Thomas, Merlin L. Robb, Jintanat Ananworanich, Mark de Souza, Praphan Phanuphak, Daniel J. Stieh, Frank L. Tomaka, Lydie Trautmann, Julie A. Ake, Denise C. Hsu, Leilani V. Francisco, Sandhya Vasan, Morgane Rolland
Publikováno v:
Med (New York, N.Y.), 3(9), 622-635. Cell Press
Background: Analytic treatment interruption (ATI) studies evaluate strategies to potentially induce remission in people living with HIV-1 but are often limited in sample size. We combined data from four studies that tested three interventions (vorino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fceabdaaf18b53ec96315bd52ebdfa73
https://pubmed.ncbi.nlm.nih.gov/35870446
https://pubmed.ncbi.nlm.nih.gov/35870446
Autor:
Peter B. Gilbert, Steven Lepore, Hongjun Bai, James I. Mullins, Sorachai Nitayaphan, Hong Zhao, Vincent Dussupt, Morgane Rolland, Paul T. Edlefsen, Sodsai Tovanabutra, Holly Janes, Kultida Poltavee, Nelson L. Michael, Supachai Rerks-Ngarm, Shelly J. Krebs, Sandhya Vasan, Yifan Li, Punnee Pitisuttithum, Joshua T. Herbeck, Jaranit Kaewkungwal, Meera Bose, Robert Gramzinski, Rebecca Grande, Eric Lewitus, Lennie Chen, Gina Donofrio, Ursula Tran, Kim G. Wong, Merlin L. Robb, Thembi Mdluli, Jerome H. Kim, Anne Marie O'Sullivan, Sevan Muhammad, Shana Miller, Bonnie M. Slike, Jenica Lee, Bahar Ahani, Eric Sanders-Buell, Robert J. O'Connell, Letzibeth Mendez-Rivera
Publikováno v:
Virus Evolution
The scale of the HIV-1 epidemic underscores the need for a vaccine. The multitude of circulating HIV-1 strains together with HIV-1’s high evolvability hints that HIV-1 could adapt to a future vaccine. Here, we wanted to investigate the effect of va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac39a74d79d22424517d39ec4deb589e
https://doi.org/10.1093/ve/veab057
https://doi.org/10.1093/ve/veab057
Autor:
Aljawharah Alrubayyi, Sorachai Nitayaphan, Gina Donofrio, Punnee Pitisuttihum, Ivelin S. Georgiev, Dominic Paquin-Proulx, Rebecca Grande, Eric D. Brown, Sandhya Vasan, Anna Lee, Ningbo Jian, Letzibeth Mendez-Rivera, Sodsai Tovanabutra, Agnès-Laurence Chenine, Yifan Li, Jerome H. Kim, Victoria R. Polonis, Galit Alter, Thembi Mdluli, Robert Gramzinski, Nelson L. Michael, Robert J. O'Connell, Margaret E. Ackerman, Ursula Tran, Merlin L. Robb, Peter B. Gilbert, Bonnie M. Slike, Shelly J. Krebs, Morgane Rolland, Paul T. Edlefsen, Michael A. Eller, Syna Kuriakose Gift, Eric Sanders-Buell, Supachai Rerks-Ngarm, Mary Bryson, Vincent Dussupt
Publikováno v:
PLoS Pathogens, Vol 17, Iss 3, p e1009386 (2021)
[This corrects the article DOI: 10.1371/journal.ppat.1009101.].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3235bb8c795fdeaec487c24cb13b0ca3
https://doaj.org/article/ea4fb3ac1eac43f48970836217c74d35
https://doaj.org/article/ea4fb3ac1eac43f48970836217c74d35
Autor:
Sorachai Nitayaphan, Agnès-Laurence Chenine, Yifan Li, Galit Alter, Peter B. Gilbert, Robert Gramzinski, Mary Bryson, Margaret E. Ackerman, Merlin L. Robb, Thembi Mdluli, Letzibeth Mendez-Riveria, Morgane Rolland, Rebecca Grande, Sodsai Tovanabutra, Paul T. Edlefsen, Ivelin S. Georgiev, Eric P. Brown, Bonnie M. Slike, Vincent Dussupt, Anna Lee, Aljawharah Alrubayyi, Michael A. Eller, Sandhya Vasan, Eric Sanders-Buell, Ningbo Jian, Ursula Tran, Nelson L. Michael, Syna Gift, Gina Donofrio, Punnee Pitisuttihum, Robert J. O'Connell, Jerome H. Kim, Victoria R. Polonis, Dominic Paquin-Proulx, Shelly J. Krebs, Supachai Rerks-Ngarm
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 16, Iss 12, p e1009101 (2020)
PLoS Pathogens, Vol 16, Iss 12, p e1009101 (2020)
The RV144 vaccine efficacy clinical trial showed a reduction in HIV-1 infections by 31%. Vaccine efficacy was associated with stronger binding antibody responses to the HIV Envelope (Env) V1V2 region, with decreased efficacy as responses wane. High l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc2051343a73dc082c71bb56c847a36
http://europepmc.org/articles/PMC7748270
http://europepmc.org/articles/PMC7748270